非瓣膜性房颤患者-话题@MedSci

#非瓣膜性房颤患者#

26篇内容 | 541人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1819544, encodeId=c64518195448c, content=<a href='/topic/show?id=567f9954412' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤患者#</a>, objectTitle=BMJ：心脏复律可降低新诊断非瓣膜性房颤患者不良预后风险, objectType=article, longId=219448, objectId=7088219448e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7088219448e5, replyNumber=0, likeNumber=46, createdTime=2022-03-09, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7088219448e5, moduleTitle=BMJ：心脏复律可降低新诊断非瓣膜性房颤患者不良预后风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7088219448e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819543, encodeId=fee5181954320, content=<a href='/topic/show?id=567f9954412' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤患者#</a>, objectTitle=2021 ESC：利伐沙班显著降低肾功能保留的非瓣膜性房颤患者的肾功能下降风险, objectType=article, longId=216628, objectId=47192166282f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47192166282f, replyNumber=0, likeNumber=40, createdTime=2022-05-31, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47192166282f, moduleTitle=2021 ESC：利伐沙班显著降低肾功能保留的非瓣膜性房颤患者的肾功能下降风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47192166282f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819542, encodeId=4efb181954249, content=<a href='/topic/show?id=567f9954412' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤患者#</a>, objectTitle=Eur Heart J：非瓣膜性房颤患者持续服用口服抗凝药的预测因子、时间进程和结局, objectType=article, longId=214455, objectId=7be82144553e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7be82144553e, replyNumber=0, likeNumber=36, createdTime=2022-01-04, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7be82144553e, moduleTitle=Eur Heart J：非瓣膜性房颤患者持续服用口服抗凝药的预测因子、时间进程和结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7be82144553e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819541, encodeId=f50a181954110, content=<a href='/topic/show?id=567f9954412' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤患者#</a>, objectTitle=JACC：糖尿病前期也可增加非瓣膜性房颤患者的卒中风险, objectType=article, longId=207827, objectId=3f7620e82759, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f7620e82759, replyNumber=0, likeNumber=41, createdTime=2021-03-15, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f7620e82759, moduleTitle=JACC：糖尿病前期也可增加非瓣膜性房颤患者的卒中风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f7620e82759)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819540, encodeId=a3a918195409d, content=<a href='/topic/show?id=567f9954412' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤患者#</a>, objectTitle=JAHA：血压变异性对非瓣膜性房颤患者不良事件的影响, objectType=article, longId=205054, objectId=cefe2050546c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cefe2050546c, replyNumber=0, likeNumber=39, createdTime=2021-08-30, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cefe2050546c, moduleTitle=JAHA：血压变异性对非瓣膜性房颤患者不良事件的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cefe2050546c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819539, encodeId=e285181953906, content=<a href='/topic/show?id=567f9954412' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤患者#</a>, objectTitle=Stroke：非瓣膜性房颤患者卒中发作后早期开始直接口服抗凝药对短期和长期结局的影响, objectType=article, longId=186699, objectId=44a91866995e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44a91866995e, replyNumber=0, likeNumber=48, createdTime=2020-10-28, rootId=0, userName=mjldent, userId=5662228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44a91866995e, moduleTitle=Stroke：非瓣膜性房颤患者卒中发作后早期开始直接口服抗凝药对短期和长期结局的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=44a91866995e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819537, encodeId=dacd181953ea0, content=<a href='/topic/show?id=567f9954412' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤患者#</a>, objectTitle=2019 ESO指南：卒中或短暂性脑缺血发作以及非瓣膜性房颤患者卒中和其他血栓栓塞事件二级预防抗栓治疗, objectType=article, longId=165554, objectId=60da165554b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60da165554b1, replyNumber=0, likeNumber=26, createdTime=2020-03-11, rootId=0, userName=mjldent, userId=5662228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60da165554b1, moduleTitle=2019 ESO指南：卒中或短暂性脑缺血发作以及非瓣膜性房颤患者卒中和其他血栓栓塞事件二级预防抗栓治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60da165554b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819538, encodeId=2f181819538bc, content=<a href='/topic/show?id=567f9954412' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤患者#</a>, objectTitle=Chest：非瓣膜性房颤患者四种口服抗凝血剂的有效性和安全性评估, objectType=article, longId=166308, objectId=02b116630814, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02b116630814, replyNumber=0, likeNumber=37, createdTime=2019-05-31, rootId=0, userName=mjldent, userId=5662228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02b116630814, moduleTitle=Chest：非瓣膜性房颤患者四种口服抗凝血剂的有效性和安全性评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=02b116630814)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819535, encodeId=ec4d1819535b7, content=<a href='/topic/show?id=567f9954412' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤患者#</a>, objectTitle=JAHA：非瓣膜性房颤患者口服抗凝剂类型与痴呆风险的关系, objectType=article, longId=152787, objectId=9f72152e871d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f72152e871d, replyNumber=0, likeNumber=37, createdTime=2019-01-02, rootId=0, userName=mjldent, userId=5662228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f72152e871d, moduleTitle=JAHA：非瓣膜性房颤患者口服抗凝剂类型与痴呆风险的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f72152e871d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819536, encodeId=823a181953665, content=<a href='/topic/show?id=567f9954412' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤患者#</a>, objectTitle=Circulation：非瓣膜性房颤患者围手术期抗凝：DOACs vs华法林, objectType=article, longId=153169, objectId=dfd415316946, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dfd415316946, replyNumber=0, likeNumber=39, createdTime=2019-10-15, rootId=0, userName=mjldent, userId=5662228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dfd415316946, moduleTitle=Circulation：非瓣膜性房颤患者围手术期抗凝：DOACs vs华法林, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dfd415316946)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819532, encodeId=d1e31819532c2, content=<a href='/topic/show?id=567f9954412' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤患者#</a>, objectTitle=J Thromb Haemost：非瓣膜性房颤患者：利伐沙班vs阿哌沙班, objectType=article, longId=118427, objectId=984711842e9a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=984711842e9a, replyNumber=0, likeNumber=43, createdTime=2018-06-19, rootId=0, userName=mjldent, userId=5662228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=984711842e9a, moduleTitle=J Thromb Haemost：非瓣膜性房颤患者：利伐沙班vs阿哌沙班, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=984711842e9a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819534, encodeId=43151819534f4, content=<a href='/topic/show?id=567f9954412' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤患者#</a>, objectTitle=Circulation：非瓣膜性房颤患者：NOAC与VKA谁是阿司匹林的更佳拍档？, objectType=article, longId=134289, objectId=c5a613428989, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5a613428989, replyNumber=0, likeNumber=54, createdTime=2019-01-09, rootId=0, userName=mjldent, userId=5662228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5a613428989, moduleTitle=Circulation：非瓣膜性房颤患者：NOAC与VKA谁是阿司匹林的更佳拍档？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5a613428989)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819530, encodeId=b37b1819530c1, content=<a href='/topic/show?id=567f9954412' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤患者#</a>, objectTitle=Stroke：既往卒中或TIA的非瓣膜性房颤患者：3种NOACs vs华法林, objectType=article, longId=108547, objectId=c68710854ef0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c68710854ef0, replyNumber=0, likeNumber=39, createdTime=2018-07-17, rootId=0, userName=mjldent, userId=5662228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c68710854ef0, moduleTitle=Stroke：既往卒中或TIA的非瓣膜性房颤患者：3种NOACs vs华法林, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c68710854ef0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819533, encodeId=e1861819533c0, content=<a href='/topic/show?id=567f9954412' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤患者#</a>, objectTitle=Eur J Clin Pharmacol：非瓣膜性房颤患者初始用药：达比加群还是维生素K拮抗剂？, objectType=article, longId=119554, objectId=379c11955440, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=379c11955440, replyNumber=0, likeNumber=33, createdTime=2018-07-02, rootId=0, userName=mjldent, userId=5662228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=379c11955440, moduleTitle=Eur J Clin Pharmacol：非瓣膜性房颤患者初始用药：达比加群还是维生素K拮抗剂？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=379c11955440)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819531, encodeId=9246181953186, content=<a href='/topic/show?id=567f9954412' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤患者#</a>, objectTitle=Int J Clin Pract:肾功能是否影响使用维生素K拮抗剂的非瓣膜性房颤患者抗凝控制？, objectType=article, longId=117839, objectId=06ed11e83930, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06ed11e83930, replyNumber=0, likeNumber=0, createdTime=2018-08-25, rootId=0, userName=mjldent, userId=5662228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06ed11e83930, moduleTitle=Int J Clin Pract:肾功能是否影响使用维生素K拮抗剂的非瓣膜性房颤患者抗凝控制？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=06ed11e83930)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819529, encodeId=f869181952952, content=<a href='/topic/show?id=567f9954412' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤患者#</a>, objectTitle=JAMA：达比加群vs.华法林-预防非瓣膜性房颤患者发生骨折哪个更好？, objectType=article, longId=93326, objectId=c27593326f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c27593326f5, replyNumber=0, likeNumber=39, createdTime=2017-10-27, rootId=0, userName=mjldent, userId=5662228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c27593326f5, moduleTitle=JAMA：达比加群vs.华法林-预防非瓣膜性房颤患者发生骨折哪个更好？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c27593326f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819528, encodeId=1fa3181952826, content=<a href='/topic/show?id=567f9954412' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤患者#</a>, objectTitle=JAHA：非瓣膜性房颤患者抗凝治疗大出血并发症和耐受性分析！, objectType=article, longId=89007, objectId=b5268900e06, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5268900e06, replyNumber=0, likeNumber=37, createdTime=2017-09-27, rootId=0, userName=mjldent, userId=5662228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5268900e06, moduleTitle=JAHA：非瓣膜性房颤患者抗凝治疗大出血并发症和耐受性分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5268900e06)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819525, encodeId=eaa51819525a5, content=<a href='/topic/show?id=567f9954412' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤患者#</a>, objectTitle=2015NICE技术评估指南——依度沙班预防非瓣膜性房颤患者卒中和全身性栓塞（TA355）发布, objectType=article, longId=79986, objectId=4b64e998681, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b64e998681, replyNumber=0, likeNumber=39, createdTime=2017-08-05, rootId=0, userName=mjldent, userId=5662228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b64e998681, moduleTitle=2015NICE技术评估指南——依度沙班预防非瓣膜性房颤患者卒中和全身性栓塞（TA355）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4b64e998681)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819527, encodeId=357f181952e97, content=<a href='/topic/show?id=567f9954412' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤患者#</a>, objectTitle=2017 ACC专家共识：非瓣膜性房颤患者围术期抗凝治疗的决策路径, objectType=article, longId=87250, objectId=95bb8e250c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95bb8e250c5, replyNumber=0, likeNumber=24, createdTime=2017-01-31, rootId=0, userName=mjldent, userId=5662228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95bb8e250c5, moduleTitle=2017 ACC专家共识：非瓣膜性房颤患者围术期抗凝治疗的决策路径, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=95bb8e250c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819526, encodeId=aa0918195265d, content=<a href='/topic/show?id=567f9954412' target=_blank style='color:#2F92EE;'>#非瓣膜性房颤患者#</a>, objectTitle=JACC：达比加群可降低亚洲非瓣膜性房颤患者的AKI风险, objectType=article, longId=83187, objectId=96138318e28, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96138318e28, replyNumber=0, likeNumber=45, createdTime=2017-08-06, rootId=0, userName=mjldent, userId=5662228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96138318e28, moduleTitle=JACC：达比加群可降低亚洲非瓣膜性房颤患者的AKI风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96138318e28)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

非瓣膜性房颤患者

2020-05-29

仁医06 (审核中...)

前往app查看评论内容

#非瓣膜性房颤患者#

BMJ：心脏复律可降低新诊断非瓣膜性房颤患者不良预后风险

2022-03-09

仁医06 (审核中...)

前往app查看评论内容

#非瓣膜性房颤患者#

2021 ESC：利伐沙班显著降低肾功能保留的非瓣膜性房颤患者的肾功能下降风险

2022-05-31

仁医06 (审核中...)

前往app查看评论内容

#非瓣膜性房颤患者#

Eur Heart J：非瓣膜性房颤患者持续服用口服抗凝药的预测因子、时间进程和结局

2022-01-04

仁医06 (审核中...)

前往app查看评论内容

#非瓣膜性房颤患者#

JACC：糖尿病前期也可增加非瓣膜性房颤患者的卒中风险

2021-03-15

仁医06 (审核中...)

前往app查看评论内容

#非瓣膜性房颤患者#

JAHA：血压变异性对非瓣膜性房颤患者不良事件的影响

2021-08-30

mjldent (审核中...)

前往app查看评论内容

#非瓣膜性房颤患者#

Stroke：非瓣膜性房颤患者卒中发作后早期开始直接口服抗凝药对短期和长期结局的影响

2020-10-28

mjldent (审核中...)

前往app查看评论内容

#非瓣膜性房颤患者#

2019 ESO指南：卒中或短暂性脑缺血发作以及非瓣膜性房颤患者卒中和其他血栓栓塞事件二级预防抗栓治疗

2020-03-11

mjldent (审核中...)

前往app查看评论内容

#非瓣膜性房颤患者#

Chest：非瓣膜性房颤患者四种口服抗凝血剂的有效性和安全性评估

2019-05-31

mjldent (审核中...)

前往app查看评论内容

#非瓣膜性房颤患者#

JAHA：非瓣膜性房颤患者口服抗凝剂类型与痴呆风险的关系

2019-01-02

mjldent (审核中...)

前往app查看评论内容

#非瓣膜性房颤患者#

Circulation：非瓣膜性房颤患者围手术期抗凝：DOACs vs华法林

2019-10-15

mjldent (审核中...)

前往app查看评论内容

#非瓣膜性房颤患者#

J Thromb Haemost：非瓣膜性房颤患者：利伐沙班vs阿哌沙班

2018-06-19

mjldent (审核中...)

前往app查看评论内容

#非瓣膜性房颤患者#

Circulation：非瓣膜性房颤患者：NOAC与VKA谁是阿司匹林的更佳拍档？

2019-01-09

mjldent (审核中...)

前往app查看评论内容

#非瓣膜性房颤患者#

Stroke：既往卒中或TIA的非瓣膜性房颤患者：3种NOACs vs华法林

2018-07-17

mjldent (审核中...)

前往app查看评论内容

#非瓣膜性房颤患者#

Eur J Clin Pharmacol：非瓣膜性房颤患者初始用药：达比加群还是维生素K拮抗剂？

2018-07-02

mjldent (审核中...)

前往app查看评论内容

#非瓣膜性房颤患者#

Int J Clin Pract:肾功能是否影响使用维生素K拮抗剂的非瓣膜性房颤患者抗凝控制？

2018-08-25

mjldent (审核中...)

前往app查看评论内容

#非瓣膜性房颤患者#

JAMA：达比加群vs.华法林-预防非瓣膜性房颤患者发生骨折哪个更好？

2017-10-27

mjldent (审核中...)

前往app查看评论内容

#非瓣膜性房颤患者#

JAHA：非瓣膜性房颤患者抗凝治疗大出血并发症和耐受性分析！

2017-09-27

mjldent (审核中...)

前往app查看评论内容

#非瓣膜性房颤患者#

2015NICE技术评估指南——依度沙班预防非瓣膜性房颤患者卒中和全身性栓塞（TA355）发布

2017-08-05

mjldent (审核中...)

前往app查看评论内容

#非瓣膜性房颤患者#

2017 ACC专家共识：非瓣膜性房颤患者围术期抗凝治疗的决策路径

2017-01-31

mjldent (审核中...)

前往app查看评论内容

#非瓣膜性房颤患者#

JACC：达比加群可降低亚洲非瓣膜性房颤患者的AKI风险

2017-08-06

科室
- - 订阅+
  - 更多科室
工具
服务